The Enterprise Value as of November 2024 (TTM) for Enzon Pharmaceuticals, Inc. (ENZN) is -40291832.00

According to Enzon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -40291832.00. This represents a change of 7.78% compared to the average of -37383373.48 of the last 4 quarters.

Enzon Pharmaceuticals, Inc. (ENZN) Historical Enterprise Value (quarterly & annually)

How has ENZN Enterprise Value performed in the past?

The mean historical Enterprise Value of Enzon Pharmaceuticals, Inc. over the last ten years is -7312391.65. The current -40291832.00 Enterprise Value has changed 55.00% with respect to the historical average. Over the past ten years (40 quarters), ENZN's Enterprise Value was at its highest in in the September 2015 quarter at 22.60M. The Enterprise Value was at its lowest in in the March 2024 quarter at -40180676.25.

Enzon Pharmaceuticals, Inc. (ENZN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Enzon Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Enzon Pharmaceuticals, Inc. (ENZN) Average Enterprise Value

How has ENZN Enterprise Value performed in the past?

The current Enterprise Value of Enzon Pharmaceuticals, Inc. (ENZN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Enzon Pharmaceuticals, Inc. (ENZN) Enterprise Value vs. Peers

How is ENZN’s Enterprise Value compared to its peers?

Enzon Pharmaceuticals, Inc.’s Enterprise Value is less than PMV Pharmaceuticals, Inc. (48.13M), less than NewAmsterdam Pharma Company N.V. (1.09B), less than Tempest Therapeutics, Inc. (14.13M), less than IO Biotech, Inc. (-20857526.00), less than Molecular Pharmacology (USA), Ltd. (0), less than Curative Biotechnology, Inc. (10.29M), less than Kineta, Inc. (0), less than OncoVista Innovative Therapies, Inc. (6.78M), less than Neurobiological Technologies, Inc. (0), less than Polydex Pharmaceuticals Limited (0), less than Cyclacel Pharmaceuticals, Inc. (0), less than Living Cell Technologies Limited (7.95M), less than MultiCell Technologies, Inc. (-4908679.00), less than Institute of Biomedical Research Corp. (7.73M), less than Health Sciences Group, Inc. (50.10K), less than Mymetics Corporation (10.00M), less than Eliem Therapeutics, Inc. (0), less than Molecular Partners AG (75.33M), less than Opthea Limited (119.64M), less than PureTech Health plc (57.48M), less than Acrivon Therapeutics, Inc. Common Stock (656.58M), less than null (314.94M), less than null (201.35M),

Build a custom stock screener for Enzon Pharmaceuticals, Inc. (ENZN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enzon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Enzon Pharmaceuticals, Inc. (ENZN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Enzon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.